跳至主要内容
临床试验/ACTRN12614001125617
ACTRN12614001125617已完成未知

Treatment efficacy of azithromycin 1g versus seven days doxycycline (100mg twice a day) for the treatment of rectal chlamydia among men who have sex with men – a double-blind randomized controlled trial

niversity of Melbourne0 个研究点目标入组 625 人开始时间: 2014年10月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
625

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
Male

入选标准

  • Consecutive English-speaking men aged 16 years or older, with rectal chlamydia meeting the eligibility criteria will be recruited and followed up for 4 weeks.
  • Inclusion criteria
  • * Men who report male to male sexual contact and are aged 16 years or older who test positive for rectal chlamydia using a Nucleic Acid Amplification Test (NAAT).
  • * Adequate English and comprehension skills to give informed consent

排除标准

  • Men will be excluded:
  • i. they present with proctitis/other symptoms.
  • ii. are concurrently diagnosed with another bacterial STI
  • iii. Self-reported use of antibiotics in the last 2 weeks
  • iv. Known contraindications to the use of azithromycin or doxycycline including allergy

研究者

发起方
niversity of Melbourne

相似试验